Popular search terms:
Search Results
32 results found-
Lernen Sie uns kennen und erfahren Sie mehr über Menschen, Projekte und was in der Welt von CSL Behring passiert.
https://www.cslbehring.de/news/2021 -
Lernen Sie uns kennen und erfahren Sie mehr über Menschen, Projekte und was in der Welt von CSL Behring passiert.
https://www.cslbehring.de/news/2025 -
SMC accepts CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) for use on an interim basis in Scotland as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors
https://www.cslbehring.de/news/2024/pm-hemgenix-scottland -
We are a leader in the development and introduction of innovative therapies that can treat rare and serious diseases.
https://www.cslbehring.de/en-us/our-company/leading-the-way -
Lernen Sie uns kennen und erfahren Sie mehr über Menschen, Projekte und was in der Welt von CSL Behring passiert.
https://www.cslbehring.de/news/2022 -
CSL Behring's driving force is the promise to save lives and improve patients' quality of life.
https://www.cslbehring.de/en-us/our-company -
CSL Behring is a global leader in biotechnology with the aim of saving lives and improving the quality of life for patients.
https://www.cslbehring.de/en-us/ -
CSL Dispatches First Australian Made Doses of the AstraZeneca COVID 19 Vaccine
https://www.cslbehring.de/en-us/news/2021/pm-csl-covid19-vaccine -
Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France.
https://www.cslbehring.de/en-us/news/2024/pm-eu-patients-hemgenix